- Intravenous therapy is becoming an essential component of modern healthcare due to its ability to deliver fluids, medications, and nutrients directly into the bloodstream with rapid therapeutic effects
- The growing burden of conditions such as cancer, gastrointestinal disorders, and immune deficiencies is amplifying the need for long-term intravenous treatment solutions across hospitals and specialty clinics
- North America dominated the intravenous therapy (IV) market with the largest revenue share of 38.9% in 2024, driven by the presence of advanced healthcare infrastructure, high prevalence of chronic conditions, and increased adoption of home-based IV therapies
- Asia-Pacific region is expected to witness the highest growth rate in the global intravenous therapy (IV) market, driven by expanding healthcare infrastructure, increasing medical tourism, growing population base with chronic conditions, and the rising affordability and accessibility of IV therapy products across emerging economies
- The polyvinyl chloride segment held the largest revenue share in 2024, owing to its durability, flexibility, and cost-efficiency. It is widely used in IV bags and tubing due to its excellent compatibility with medications and sterilization methods, making it a preferred material in both hospital and outpatient settings. The widespread adoption of PVC is also attributed to its easy processing and strong barrier properties, ensuring product safety during infusion
